Extract
We read with great interest the article published in your journal by Barochia et al. [1]. The authors reported that the serum level of small high-density lipoprotein particles measured by nuclear magnetic resonance spectroscopy (S-HDLPNMR) is negatively associated with death or lung transplantation in idiopathic pulmonary fibrosis (IPF) [1]. The finding is consistent with the protective activity of high-density lipoprotein (HDL) in tissue injury and fibrosis reported in previous studies [2–5].
Abstract
Measurement of serum total HDL particles may be potentially useful as a biomarker in idiopathic pulmonary fibrosis https://bit.ly/3K7D3q6
Footnotes
Author contributions: Approval and writing the correspondence draft: T. Yasuma, C.N. D'Alessandro-Gabazza, H. Fujimoto, T. Kobayashi and E.C. Gabazza.
Conflict of interest: T. Yasuma reports grants from Shionogi, outside the submitted work.
Conflict of interest: C.N. D'Alessandro-Gabazza reports grants from Shionogi Pharmaceutical Inc., Astellas Pharmaceuticals Inc. and Asahi Kassei, outside the submitted work.
Conflict of interest: H. Fujimoto reports grants from Chugai, Pfizer, ONO, TAIHO, Boehringer Ingelheim and Eli Lilly, outside the submitted work.
Conflict of interest: T. Kobayashi reports grants and personal fees from Chugai, Pfizer, ONO, Boehringer Ingelheim and Eli Lilly, grants from TAIHO, outside the submitted work.
Conflict of interest: E.C. Gabazza reports grants from Shionogi Pharmaceutical Inc., Astellas Pharmaceuticals Inc. and Asahi Kassei, outside the submitted work.
- Received December 16, 2021.
- Accepted December 26, 2021.
- Copyright ©The authors 2022. For reproduction rights and permissions contact permissions{at}ersnet.org
LIBRARY USERS
Log in through your institution
Purchase access
